Search

everythinglearnresearchcommunity

for

Search:↓

A woman's excessive hair growth was linked to a rare case of high testosterone caused by a prolactin-producing pituitary tumor.

Hormone imbalances from the pituitary, thyroid, and adrenal glands can cause infertility, but treating these disorders can improve fertility.

Long-term use of oral contraceptives, especially starting before age 20, may increase the risk of early-onset breast cancer.

Higher doses of oestradiol implants improve bone density in postmenopausal women.

Human scalp hair follicles can be used to study how prolactin affects hair growth and cell death.

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

Progesterone and allopregnanolone increase glycine release in rat brain cells.

Prolactin levels do not control the start of winter fur growth in mink.

TNFα, IFNγ, and Substance P significantly affect prolactin levels in human skin, suggesting new treatments for skin and hair conditions.

Inhibiting prolactin reduces hair follicle activation in cashmere goats.

Prolactin affects skin health and may lead to new treatments for skin and hair issues.

Vitamin D is needed for metformin to lower prolactin effectively.

Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

About 2.2% of women with symptoms of high male hormones have a mild form of congenital adrenal hyperplasia, and measuring a specific hormone level can accurately diagnose it.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Primary care for PCOS focuses on lifestyle changes, medication based on symptoms, and mental health, with diabetes screening and specialist referral for severe cases.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

The conclusion is that lifestyle changes and weight loss are first-line treatments for infertility due to anovulation, with various medications and assisted reproductive technologies as additional options.

ChatGPT-5 can pass the endocrinology exam but isn't fully reliable for clinical decisions yet.

Finasteride may decrease semen quality but not harm sperm production, and stopping the drug can improve semen quality; hyperprolactinemia can cause infertility but is treatable with medication.

PCOS management involves medication, lifestyle changes, and personalized treatment to address symptoms and improve health.

Hirsutism in teens is often due to polycystic ovarian syndrome and needs careful assessment and support.

Menopause is a clear hormonal transition in women, while men experience a gradual testosterone decline, with some needing lifestyle changes and targeted therapy.

Continuous glucose monitoring and GLP-1 receptor agonists improve diabetes management, but personalized care and education are crucial.

Non-classic congenital adrenal hyperplasia (NCCAH) can mimic PCOS and requires genetic testing for proper diagnosis and treatment.